CHOLANGIOCARCINOMA - CURRENT TREATMENT OPTIONS

被引：82
作者：
Friman, S. [1 ]
机构：
[1] Sahlgrens Univ Hosp, Transplant Inst, S-41345 Gothenburg, Sweden
来源：
SCANDINAVIAN JOURNAL OF SURGERY | 2011年 / 100卷 / 01期
关键词：
CA; 19-9; cholangiocarcinoma; liver transplantation; liver resection; primary sclerosing cholangitis; tumour marker; PRIMARY SCLEROSING CHOLANGITIS; LIVER-TRANSPLANTATION; INTRAHEPATIC CHOLANGIOCARCINOMA; HEPATOBILIARY MALIGNANCY; HILAR CHOLANGIOCARCINOMA; SERUM CA-19-9; HEPATITIS-C; CARCINOMA; EXPERIENCE; SURVIVAL;
D O I：
10.1177/145749691110000106
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：30 / 34
页数：5
相关论文
共 33 条
  • [1] Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial
    Bengala, C.
    Bertolini, F.
    Malavasi, N.
    Boni, C.
    Aitini, E.
    Dealis, C.
    Zironi, S.
    Depenni, R.
    Fontana, A.
    Del Giovane, C.
    Luppi, G.
    Conte, P.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 102 (01) : 68 - 72
  • [2] BISMUTH H, 1975, SURG GYNECOL OBSTET, V140, P170
  • [3] CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis
    Björnsson, E
    Kilander, A
    Olsson, R
    [J]. LIVER, 1999, 19 (06): : 501 - 508
  • [4] Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis
    Boberg, Kirsten Muri
    Jebsen, Peter
    Clausen, Ole Petter
    Foss, Aksel
    Aabakken, Lars
    Schrumpf, Erik
    [J]. JOURNAL OF HEPATOLOGY, 2006, 45 (04) : 568 - 574
  • [5] Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy
    Brandsæter, B
    Isoniemi, H
    Broomé, U
    Olausson, M
    Bäckman, L
    Hansen, B
    Schrumpf, E
    Oksanen, A
    Ericzon, BG
    Höckerstedt, K
    Mäkisalo, H
    Kirkegaard, P
    Friman, S
    Bjorol, K
    [J]. JOURNAL OF HEPATOLOGY, 2004, 40 (05) : 815 - 822
  • [6] Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis
    Broome, U
    Olsson, R
    Loof, L
    Bodemar, G
    Hultcrantz, R
    Danielsson, A
    Prytz, H
    SandbergGertzen, H
    Wallerstedt, S
    Lindberg, G
    [J]. GUT, 1996, 38 (04) : 610 - 615
  • [7] Risk factors for biliary tract carcinogenesis
    Chapman, RW
    [J]. ANNALS OF ONCOLOGY, 1999, 10 : 308 - 311
  • [8] Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma
    De Vreede, I
    Steers, JL
    Burch, PA
    Rosen, CB
    Gunderson, LL
    Haddock, MG
    Burgart, L
    Gores, GJ
    [J]. LIVER TRANSPLANTATION, 2000, 6 (03) : 309 - 316
  • [9] FLANIGAN DP, 1977, CANCER-AM CANCER SOC, V40, P880, DOI 10.1002/1097-0142(197708)40:2<880::AID-CNCR2820400242>3.0.CO
  • [10] 2-X
1234